PineBridge Investments’s Regenxbio RGNX Stock Holding History

PineBridge Investments’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-17,528	Closed	-$718K	–	973
2019 Q4	$718K	Sell	17,528 -10,826	-38%	-$428K	0.01%	741
2019 Q3	$1.01M	Buy	28,354 +2,021	+8%	+$81.9K	0.02%	756
2019 Q2	$1.35M	Buy	26,333 +19,222	+270%	+$960K	0.02%	521
2019 Q1	$408K	Sell	7,111 -14,899	-68%	-$738K	0.01%	738
2018 Q4	$924K	Sell	22,010 -472	-2%	-$27.7K	0.02%	537
2018 Q3	$1.7M	Sell	22,482 -1,335	-6%	-$96.2K	0.03%	436
2018 Q2	$1.71M	Buy	+23,817	New	+$1.14M	0.04%	430

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

PineBridge Investments's RGNX Position: Q1 2020 in Review

PineBridge Investments sold out of Regenxbio (RGNX) in Q1 2020, closing a stake of 17,528 shares — an estimated $718K sold.

PineBridge Investments first reported a position in RGNX in Q2 2018 and held it in 7 quarters. The position peaked at $1.71M in Q2 2018. 170 funds tracked by Wall St. Rank hold RGNX as of Q1 2020.

PineBridge Investments reported no remaining Regenxbio position as of Q1 2020 after selling out during the quarter.
PineBridge Investments sold 17,528 Regenxbio shares in Q1 2020, an estimated $718K.
PineBridge Investments first reported a position in Regenxbio in Q2 2018 and held it in 7 quarters.
PineBridge Investments's Regenxbio position peaked at $1.71M in Q2 2018.
170 funds tracked by Wall St. Rank held Regenxbio as of Q1 2020.

Based on PineBridge Investments's 13F filing for Q1 2020, filed 14 May 2020.